期刊文献+

丝素蛋白/牛骨形态发生蛋白及骨髓间充质干细胞复合新型组织工程骨脊柱融合的生物力学实验 被引量:4

Biomechanics of neotype tissue engineered bone in spinal fusion with bone marrow mesenchymal stem cells and bovine bone morphorgenetic protein/silk fibroin
暂未订购
导出
摘要 背景:植入材料的载体作用、细胞因子的缓释作用以及植入后利于血管、软骨、骨的长入,适当的孔隙度及材料内部的三维结构都是影响支架材料选择的因素。目的:拟运用丝素蛋白、牛骨形态发生蛋白及骨髓间充质干细胞来构建新型组织工程骨,通过脊柱融合实验对其进行生物力学分析。材料:清洁级4周龄雄性新西兰大耳白兔70只,丝素蛋白由苏州大学材料工程学院提供,牛骨形态发生蛋白由中国医学科学院提供。方法:取10只兔体外扩增骨髓间充质干细胞,接种复合于丝素蛋白/牛骨形态发生蛋白复合物上,构建组织工程骨。剩余60只兔随机分成5组:丝素蛋白/牛骨形态发生蛋白/骨髓间充质干细胞组、丝素蛋白/骨髓间充质干细胞组、丝素蛋白/牛骨形态发生蛋白组、单纯丝素蛋白组、空白对照组,12只/组。各组均咬除L5棘突建立植骨床,前4组植入对应移植物进行椎板间融合,空白对照组仅去皮质骨,不给予任何外植物。主要观察指标:X射线、三维CT及手触法检测脊柱融合情况;苏木精-伊红染色观察移植物骨组织生成情况;在轴向压缩、前屈、后伸、侧屈4种不同生理运动情况下生物力学性能测试结果。结果:①植入12周时,丝素蛋白/牛骨形态发生蛋白/骨髓间充质干细胞组100%融合,丝素蛋白/牛骨形态发生蛋白组、丝素蛋白/骨髓间充质干细胞组、单纯丝素蛋白组融合率分别为83.3%,25.0%,16.7%,空白对照组为0。②丝素蛋白/牛骨形态发生蛋白/骨髓间充质干细胞组丝素蛋白完全降解,新生骨组织已进入塑形期,向板层骨发展;丝素蛋白/牛骨形态发生蛋白丝素蛋白完全降解,新生骨组织以编织骨为主;丝素蛋白/骨髓间充质干细胞组骨岛数目较前增多,未见连续性新生骨;单纯丝素蛋白组新生骨增加不明显;空白对照组始终未见新生骨生成。③丝素蛋白/牛骨形态发生蛋白/骨髓间充质干细胞组、丝素蛋白/牛骨形态发生蛋白组体内植入的融合脊柱具有明显的稳定性,刚度、强度较好,与其余3组比较差异有显著性意义。结论:丝素蛋白是一种良好的细胞外基质材料,通过丝素蛋白体外构建的组织工程化骨植入体内进行脊柱融合是可能的。 BACKGROUND: The selection of scaffold materials is influenced by many factors, such as the implant vectors, the slow-release effect of the cytokines, the promotion effect on the growth of blood vessel, cartilage and bone after implantation, the suitable porosity, and three-dimensional structure as well. OBJECTIVE: To construct new tissue engineered bone with bone marrow mesenchymal stem cells (MSCs), bovine bone morphorgenetic protein (BMP) and silk fibroin (SF), and to explore the biomechanics of the constructed bone by spinal fusion.MATERIALS: Seventy male New Zealand white rabbits, of 4 weeks old and clean grade, were used in this study. SF was offered by Soochow University Materials and Engineering College, bovine BMP was purchased from Chinese Academy of Medical Sciences. METHODS: Tissue engineered bone was constructed in ten rabbits by inoculating MSCs, which had been amplified in vitro, onto the SF/BMP composites. Other 60 rabbits were separated into five groups (12 rabbits one group) at random: SF/BMP/MSCs group, SF/MSCs group. SF/BMP group, pure SF group, and blank control group. L~ spinous process was resected to establish the bed of bone graft, and the former four groups were implanted with corresponding grafts for the intercentrum process fusion posteriorly. In the blank control group, the bone decortieation was only performed without any graft. MAIN OUTCOME MEASURES: Spinal fusion was determined by radiography, three-dimensional CT and manual palpation method; Hematoxylin-eosin stain was employed to observe the histogenesis of bone graft; Biomechanical testing was performed at axial compression, flexion, extension and lateral bending. RESULTS: At week 12 of the implantation, 100% spinal fusion rate was achieved in the SF/BMP/MSCs group, 83.3% in the SF/BMP group, 25% in the SF/MSCs group, 16.7% in the pure SF group, and 0 in the blank control group. Both SF/BMP/MSCs and SF/BMP exhibited complete degradation, but the former developed the lamellar bone and the latter trended to the woven bone; There were many bone islands but no successive new bone in the SF/MSCs group; No bone formation was observed in the blank control group. SF/BMP/MSCs and SF/BMP showed significantly better spinal fusion than other three groups. CONCLUSION : SF is a kind of good extracellular matrix materials. It is feasible to construct tissue engineered bone with bone marrow MSCS, bovine BMP and SF for the spinal fusion in vivo.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第27期5201-5208,共8页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献34

  • 1Katz JN. Lnmbar spinal fusion. Surgical rates, costs, and complications. Spine 1995;20(Suppl 24):78-83
  • 2Boden SD. Bone repair and enhancement clinical trial design. Spine applications. Clinical Orthopaedics & Related Research 1998;355(Suppl):S336-S346
  • 3Boden SD. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 2002; 27:S26-31
  • 4Marchesi DG. Spinal fusions: bone and bone substitutes. European Spine Journal 2000;9(5):372-378
  • 5Banwart JC, Asher MA, Hassanein RS. Iliacc rest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995;20:1055-1060
  • 6Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-195
  • 7Crane GM, Ishaug SL, Mikos AG. Bone tissue engineering. Nature Medicine 1995;1(12):1322-1324
  • 8Miller MJ, Patrick CW Jr. Tissue engineering. Clinics in Plastic Surgery 2003;30(1):91-103
  • 9Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-899
  • 10Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration, Nat. Biotechnol 1998;16: 247-252

二级参考文献16

  • 1于同隐,邵正中,刘永成,钱江红,刘海鹰,邓家祺,胡德珍,赵慧玲.再生丝素和聚乙烯醇混合膜的结构、性能及其葡萄糖传感器的应用[J].高等学校化学学报,1996,17(4):651-654. 被引量:10
  • 2吴激宇,田保中,朱德安,严筱鸣,程万里,徐帼英.丝素创面保护膜的性能和应用[J].苏州丝绸工学院学报,1996,16(3):71-78. 被引量:18
  • 3味泽昭义.丝素溶解性能的研究[J].日本蚕丝学杂志,1969,38(5):356-370.
  • 4吴徽宇,苏州丝绸工学院学报,1996年,16卷,3期,71页
  • 5吴徽宇,蚕业科学,1993年,19卷,2期,105页
  • 6苏州丝绸工学院,制丝化学,1992年,76页
  • 7味泽昭义,日本蚕丝学杂志,1969年,38卷,5期,356页
  • 8Nakahara H, Goldberg VM, Caplan At. Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo [J].Clin Orthop,1992,276: 291-298.
  • 9Bruder SP,Jaiswal N,Ricalton NS,et al. Mesenchymal stem cells in osteobiology and applied bone regeneration [J].Clin Orthop, 1998,355S: S247-S256.
  • 10Goshima J,Goldberg VM,Caplan AI.The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks [J].Clin Orthop,1991,262: 298-311.

共引文献13

同被引文献171

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部